AUROBINDO PHARMA (AUROPHARMA) - Live BSE, NSE Stock Quotes - AUROBINDO PHARMA Analysis Update - Equitymaster.com
X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2015 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
McAfee Secure sites help keep you safe from identity theft, credit card fraud, spyware, spam, viruses and online scams
Proof to discard the decoupling
theory and prepare for the
crisis. Read Now
  MyStocks MEMBER'S LOGIN  

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AUROBINDO PHARMA   (AUBD)

REFRESH
Live BSE Quotes Aug 28, 2015 03:42:00 PM
Price (Rs)754.75 Open (Rs) 756.90 High (Rs) 779.40 Low (Rs) 746.00
% Change1.46 Volume 244,865 Value (Rs) 184,811,859 52-Week H/L 832.50 / 382.50
Live NSE Quotes Aug 28, 2015 3:29:59 PM
Price (Rs)758.00 Open (Rs) 751.50 High (Rs) 780.00 Low (Rs) 745.85
% Change1.70 Volume 3,663,321 Value (Rs) 2,812,038,466 52-Week H/L 832.20 / 381.50
Valuation
EPS (Rs)* 57.62 P/E Ratio (x) 13.10 Market Cap (Rs m) 219,979.44 P/BV (x) 4.27
  *Trailing 12 months earnings, excluding extraordinary / exceptional items. BSE Sensex | CNX Nifty


Charts
AUROBINDO PHARMA Stock Price Chart (Rs) - 1 Year
Loading...
 
Peer Group:
Quote & Graph
     
 S&P BSE SENSEX 
PERIOD
 DO YOU LIKE OUR NEW GRAPHS? TELL US!
Advanced Charts new

Related Views On News

Cipla Limited: On a growth drive (Cool Hand Luke)

Mar 21, 2014

Luke Verghese discusses that Cipla's financials are on a roll

GSK pharma's Open offer: Our view (Company Info)

Dec 17, 2013

Should investors take advantage of the buy back offer and offload shares of GSK Pharma?

Foreign investment in pharma; walking a thin line (What We're Reading)

Oct 9, 2013

Here is today's recommended reading list from Equitymaster...

Divi's Laboratories: Cash rich operations (Cool Hand Luke)

Sep 24, 2013

Luke Verghese discusses that Divi's Laboratories is professionally managed

Sun Pharma Advanced Research: Strong R&D focus (Cool Hand Luke)

Sep 18, 2013

The Company is being very judiciously funded through permanent capital, and unsecured debt at favourable terms

More Views on News

Most Popular

Markets are crashing. Here's what you should do(The 5 Minute Wrapup)

Aug 24, 2015

Between good news and good prices, what should long term investors choose?

Calculating Price Targets Based On the Head and Shoulder Pattern(Daily Profit Hunter)

Aug 22, 2015

Apurva Sheth shows to calculate price targets on the head and shoulder pattern

No one really knows what's going on!(The Daily Reckoning)

Aug 21, 2015

Bill Bonner on why the US 'recovery' is fake.

Who's afraid of rupee depreciation?(Maverick View)

Aug 21, 2015

In this article, Mr Tarapore discusses that why an overvalued rupee is detrimental for the economy.

India Inc. still waiting for a turn around(Chart Of The Day)

Aug 17, 2015

India Inc. yet to witness a change in fortunes. Will Modi Government walk the talk?

More

TRACK AUROBINDO PHARMA

  • Track your investment in AUROBINDO PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON AUROBINDO PHARMA

AUROBINDO PHARMA 8-QTR ANALYSIS

Detailed Quarterly Results With Charts

COMPARE AUROBINDO PHARMA WITH

MARKET STATS

  1. Go

GET IT ON GOOGLE PLAY  Equitymaster Agora Research Private Limited. McAfee SECURE sites help keep you safe from identity theft, credit card fraud, spyware, spam, viruses and online scams
Whitelist | Refer | Terms | Privacy | Contact | Advertise | About | The Equitymaster Way | Sitemap
Follow Us: